COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING MET INHIBITOR AND K-RAS INHIBITOR
PARK, Ha Yeon, CHOI, Jun Young, KIM, Na Young, PARK, Kyung Eui, LEE, Sae Hyung
Year of Publication 19.09.2024
Get full text
Year of Publication 19.09.2024
Patent
PEGYLATED INTERFERON-BETA VARIANTS
LEE, SAE HYUNG, LEE, HEE JUNG, JEONG, SEONG HOON, YOON, IN SOO, NA, DONG HEE, KIM, YOUNG DEUG, SHIN, YOUNG KEE, SONG, KYOUNG, KIM, DAE DUK
Year of Publication 04.02.2016
Get full text
Year of Publication 04.02.2016
Patent
PEGYLATED INTERFERON-BETA VARIANT
KIM, YOUNG-DEUG, LEE, SAE HYUNG, LEE, HEE JUNG, JEONG, SEONG HOON, SHIN, YOUNG-KEE, YOON, IN SOO, NA, DONG HEE, SONG, KYOUNG, KIM, DAE DUK
Year of Publication 28.01.2016
Get full text
Year of Publication 28.01.2016
Patent
POLYETHYLENE GLYCOL COMPLEX OF INTERFERON-BETA VARIANT
LEE, SAE HYUNG, LEE, HEE JUNG, JEONG, SEONG HOON, YOON, IN SOO, NA, DONG HEE, KIM, YOUNG DEUG, SHIN, YOUNG KEE, SONG, KYOUNG, KIM, DAE DUK
Year of Publication 28.01.2016
Get full text
Year of Publication 28.01.2016
Patent
Abstract 4086: ABN202 (anti-Trop-2-interferon-beta mutein): A potent antibody-cytokine fusion protein for the treatment of Trop-2 positive solid tumors
Park, Hee Geon, Lee, Hyun Kyung, Seo, Myeung Ryun, Kim, Daa Eun, Bang, Sang Beom, Lee, Ji Yang, Hong, Sung Youl, Song, Kyoung, Lee, Chan Gyu, Jeong, Hae Min, Lee, Sae Hyung, Kim, Na Young, Choi, Jun Young, Shin, Young Kee
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 4084: Potent anti-tumor activity of ABN202 (anti-EGFR antibody-interferon-beta mutein) through direct cytotoxicity and indirect immune activation against non-small cell lung cancer, regardless of EGFR mutation status
Park, Hee Geon, Cho, Sung Hun, Park, Ha Yeon, Jo, Mi Gyoung, Park, Ji Hyun, Seo, Myeung Ryun, Kim, Ji Hyun, Hong, Sung Youl, Song, Kyoung, Lee, Chan Gyu, Jeong, Hae Min, Lee, Sae Hyung, Kim, Na Young, Choi, Jun Young, Shin, Young Kee
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 311: Development of cludin-3 specific human monoclonal antibody(ABN501) as therapeutic anti-tumor agents
Choi, Hong-Seok, Sim, Euni, Kim, Na Young, Lee, Yong Jin, Lee, Sae Hyung, Park, Hayeon, Yang, Hobin, Jo, Jiwon, Seo, Myeung-Ryun, Park, Heegeon, Lee, Ji-Hye, Hong, Sungyoul, Shin, Young Kee, Choi, Jun-Young
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article